Increased Expression of CD44s in Conventional Renal Cell Carcinomas with Renal Vein or Vena Cava Thrombosis

被引:6
作者
Altinel, Mert
Arpali, Emre [1 ]
Turhan, Nesrin [2 ]
Gonenc, Faruk
Yazicioglu, Ahmet
机构
[1] Turkiye Yuksek Ihtisas Hosp, Urol Klin, Dept Urol, TR-06100 Ankara, Turkey
[2] Turkiye Yuksek Ihtisas Hosp, Dept Pathol, TR-06100 Ankara, Turkey
关键词
CD44s; Thrombus; Renal cell carcinomas;
D O I
10.1159/000167846
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Objectives: CD44 is thought to play an important role in the tumorigenesis of renal cell carcinoma (RCC). We retrospectively evaluated the expression of CD44s by immunohistochemical analysis in conventional RCC patients and in conventional RCC patients with renal vein or vena cava thrombus and investigated the differences in the pattern of expression of CD44s between the two groups. Methods: Thirty RCC specimens and four RCC specimens with renal vein and five RCC specimens with vena cava thrombus were analyzed immunohistochemically using a CD44s-specific antibody. The expression of CD44s in RCC with renal vein or vena cava thrombus was compared with the expression of CD44s in RCC without renal vein or vena cava extention. Results: Of the 30 tumor specimens without thrombus, 16 (53%) expressed CD44s. Staining was also positive in all of the nine specimens with thrombus. CD44s expression was weak in the tumour specimens without thrombus. RCC specimens with renal vein or vena cava thrombus exhibited strong positive staining for CD44s. Conclusions: The increased expression of CD44s seems to be correlated with tumor thrombus formation in renal vein or vena cava. CD44s may play a role in the formation of renal vein or vena cava extention. Copyright (C) 2008 S. Karger AG, Basel
引用
收藏
页码:452 / 455
页数:4
相关论文
共 29 条
[1]   CD44 IS THE PRINCIPAL CELL-SURFACE RECEPTOR FOR HYALURONATE [J].
ARUFFO, A ;
STAMENKOVIC, I ;
MELNICK, M ;
UNDERHILL, CB ;
SEED, B .
CELL, 1990, 61 (07) :1303-1313
[2]  
Borland G, 1998, IMMUNOLOGY, V93, P139
[3]  
CARTER WG, 1988, J BIOL CHEM, V263, P4193
[4]   TO METASTASIZE OR NOT - SELECTION OF CD44 SPLICE SITES [J].
COOPER, DL ;
DOUGHERTY, GJ .
NATURE MEDICINE, 1995, 1 (07) :635-637
[5]   COMPARISON OF IMMUNOHISTOCHEMISTRY AND RT-PCR FOR DETECTION OF CD44V-EXPRESSION, A NEW PROGNOSTIC FACTOR IN HUMAN BREAST-CANCER [J].
DALL, P ;
HEIDER, KH ;
SINN, HP ;
SKROCHANGEL, P ;
ADOLF, G ;
KAUFMANN, M ;
HERRLICH, P ;
PONTA, H .
INTERNATIONAL JOURNAL OF CANCER, 1995, 60 (04) :471-477
[6]  
Daniel L, 2001, J PATHOL, V193, P345
[7]   CD44 and melanocytic tumors: A possible role for standard CD44 in the epidermotropic spread of melanoma [J].
FernandezFigueras, MT ;
Ariza, A ;
Calatrava, A ;
Puig, L ;
FernandezVasalo, A ;
Ferrandiz, C .
JOURNAL OF CUTANEOUS PATHOLOGY, 1996, 23 (02) :133-139
[8]  
Fischer C, 1999, ANTICANCER RES, V19, P1513
[9]  
FOX SB, 1994, CANCER RES, V54, P4539
[10]   PROGNOSTIC-SIGNIFICANCE OF MORPHOLOGIC PARAMETERS IN RENAL-CELL CARCINOMA [J].
FUHRMAN, SA ;
LASKY, LC ;
LIMAS, C .
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 1982, 6 (07) :655-663